Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02891122
Other study ID # JEÛNE PREOPERATOIRE
Secondary ID
Status Completed
Phase N/A
First received September 1, 2016
Last updated September 1, 2016
Start date October 2014
Est. completion date July 2015

Study information

Verified date September 2016
Source University Hospital, Brest
Contact n/a
Is FDA regulated No
Health authority France: The Commission nationale de l’informatique et des libertés
Study type Observational

Clinical Trial Summary

This study aims to determine if prolonged fasting represents an independent risk factor for hypotension during induction of general anesthesia in the elderly.


Description:

Preoperative fasting aims to reduce the risk of adverse events (eg, inhalation), but may be responsible for dehydration whose consequence is a major hypotension. This problem of hypotension is important because it (MAP <55 mmHg) is directly correlated to the occurrence of pejorative events on the cardiac and renal level and even more so that the duration of the hypotension is long.


Recruitment information / eligibility

Status Completed
Enrollment 56
Est. completion date July 2015
Est. primary completion date July 2015
Accepts healthy volunteers No
Gender Both
Age group 70 Years and older
Eligibility Inclusion Criteria:

- Risk Score anesthetic ASA I-III

- Patients = 70 years

- Suffering from a femoral neck fracture to be treated surgically:

- either through prosthesis,

- either by intramedullary nailing (gamma nail)

Exclusion Criteria:

- Risk Score anesthetic ASA IV

- Patient on Angiotensin Converting Enzyme (ACE) inhibitors or ARBs (ARA2) within 10 hours before surgery

- Obesity (BMI> 35) or weight <40kg

- Need to make a rapid sequence induction

- Inability to achieve the femoral block (standardization of induction) or patient refusal with respect to the technique.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
France CHRU de Brest Brest

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Follow-up of the variation of the Mean arterial pressure 8 months No